Edition:
United States

Evotec AG (EVTG.DE)

EVTG.DE on Xetra

14.59EUR
24 May 2018
Change (% chg)

-- (--)
Prev Close
€14.59
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,337,339
52-wk High
€22.50
52-wk Low
€11.28

Chart for

About

Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees,... (more)

Overall

Beta: 0.64
Market Cap(Mil.): €2,103.29
Shares Outstanding(Mil.): 147.55
Dividend: --
Yield (%): --

Financials

  EVTG.DE Industry Sector
P/E (TTM): 103.01 236.60 32.60
EPS (TTM): 0.14 -- --
ROI: 5.12 -7.50 12.74
ROE: 6.28 -10.27 14.66

BRIEF-Evotec And Celgene Enter Into Strategic Oncology Partnership

* DGAP-ADHOC: EVOTEC AND CELGENE ENTER INTO STRATEGIC ONCOLOGY PARTNERSHIP

May 21 2018

BRIEF-Evotec Says Endometriosis Programme With Bayer Moves To Phase I Development

* DGAP-NEWS: EVOTEC AND BAYER ADVANCE THIRD ENDOMETRIOSIS PROGRAMME INTO PHASE I CLINICAL DEVELOPMENT Source text for Eikon: Further company coverage:

Apr 18 2018

BRIEF-Evotec AG Says ‍Plans Conversion Into European Company​

* SAYS ‍PLANS CONVERSION INTO EUROPEAN COMPANY​ Source text for Eikon: Further company coverage: (Reporting by Frankfurt Newsroom)

Mar 27 2018

Sanofi, Evotec team up for research on infectious diseases treatment

PARIS Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added on Thursday that they would form a new open innovation platform in this area, led by Evotec.

Mar 08 2018

BRIEF-Evotec, Apeiron Biologics receive milestone payment from Sanofi

* SAYS ‍EVOTEC AND APEIRON ACHIEVE FIRST MILESTONE IN IMMUNO-ONCOLOGY ALLIANCE WITH SANOFI​

Jan 08 2018

BRIEF-Evotec receives milestone payment from Boehringer Ingelheim​

* SAYS ‍EVOTEC RECEIVES CLINICAL MILESTONE AS PART OF ITS DISCOVERY ALLIANCE WITH BOEHRINGER INGELHEIM

Dec 01 2017

Earnings vs. Estimates